Inflammatory hematological markers associated with serious perioperative adverse events in cardiovascular surgery
Abstract
Introduction: The cardiovascular surgery bears a high morbidity and mortality for its nature, as well as high costs, therefore, the search of predictive tools of adverse events and perioperatory complications continue being object of clinical investigation.
Objective: To evaluate the relationship between selected inflammatory hematologic biomarkers with the emergence of perioperatory serious adverse events of the cardiovascular surgery.
Method: A design of ambispective cohort was implemented that included patients surgically intervened by cardiovascular affections during five years in the Cardiocenter from Santiago de Cuba. The studied variables were means in clinical different moments, and statistical methods were used as the bivariate analysis and relative risk, to determine the most outstanding relationships.
Results: Although the metabolic alterations and of the hydromineral balance and acid-basic were the more prevalent adverse events (68.0 %) in this surgery type, those that had a significant association with the severity were the mechanical complications (p=0000), electric (p=0002) and the neurological dysfunctions (p=0019), a narrow connection was evidenced (p=0000) of the selected biomarkers with the adverse events related with the surgical procedure.
Conclusions: The frequency of serious perioperatory adverse events is compatible with that pointed out in the national and international bibliography and a narrow relationship of them is revealed with the new hematological inflammatory markers studied, therefore they could be very useful to reinforce the surveillance, precocious diagnosis and therapy of complications and to revert the high morbidity and mortality of these patients.
Downloads
References
1.Rivera Granada MC, Henao Caicedo YT. Cuidado Preoperatorio en Cirugía Cardíaca: Hacia un Protocolo Estandarizado. [Tesis]. Colombia:Fundación Universitaria del Área Andina Facultad de Ciencias de la Salud y el Deporte Enfermería Pereira; 2025. [citado 11/11/2025]. Disponible en: https://digitk.areandina.edu.co/server/api/core/bitstreams/25eebcba-39f3-4b65-90d0-8567bd3fa320/content
2.Abboud P, Petersen TR, Ehsanian R, Miklos D, Kertai MD, Abrams B, et al. Advances in Medicine: The Convergence of Data, Experience, and Story. Semin ars in Cardiothoracic and Vascular Anesthesia. 2025[citado 11/11/2025]; 29(4):237-39. Disponible en: https://journals.sagepub.com/doi/10.1177/10892532251391796?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
3.Rojas Arriaga AI. Factores perioperatorios demográficos, clínicos y paraclínicos aociados a mortalidad en cirugía cardíaca. [Tesis]. Mexico:Universidad Nacional Autónoma de Mexico; 2025. [citado 11/11/2025]. Disponible en: https://ru.dgb.unam.mx/items/db612766-0403-484e-9b51-df09e5bc7717
4.Zelada-Pineda JA, Gopar-Nieto R, Rojas-Velasco G, Manzur-Sandoval D. Impact of postoperative syndromes on adverse outcomes in cardiac surgery with cardiopulmonary bypass: A retrospective study on morbidity and in-hospital mortality.Cir Cardiov. 2025[citado 11/11/2025]. Disponible en: https://www.sciencedirect.com/science/article/pii/S1134009625000774?via%3Dihub
5.Silva-Tejada H, Sisniegas-Razón J, Martínez-Ninanqui F, Díaz-Chávez Z, Ríos-Ortega JC. Morbimortalidad perioperatoria de las cirugías cardíacas en el Instituto Nacional Cardiovascular, Lima, Perú, durante el año 2023. Arch Peru Cardiol Cir Cardiovasc. 2025[citado 11/11/2025]; 6(1):36-43. Disponible en: https://apcyccv.org.pe/index.php/apccc/article/view/446/621
6.Felizola Rodríguez A, Martí Pérez JC, Ginarte Rodríguez G, Berdión Sevilla J, Luque Borjas EA. Complicaciones mayores en el período posoperatorio inmediato de la cirugía cardiaca abierta. MEDISAN. 2005[citado 11/11/2025]; 9(1). Disponible en: https://www.redalyc.org/pdf/3684/368445007003.pdf
7.Castano M, Maiorano P, Castillo L, Meana B, Ramos B, Martín-Gutiérrez E, et al. Utilidad de la procalcitonina como biomarcador en cirugía cardiaca. Cirugía Cardiovascular. 2025[citado 11/11/2025]; 32(1)26–33. Disponible en: https://www.sciencedirect.com/science/article/pii/S1134009624001050?via%3Dihub
8.Zilu Liang, Shaoyan Lin, Huimei Sun, Liao Yingying, Cuishan Chen, Muchen Zhang. Fear of disease progression in patients after open-heart surgery: A cross-sectional study. Heart & Lung. 2025[citado 11/11/2025]; 73:214-20. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0147956325001256?via%3Dihub
9.Girón Gutiérrez YT, Fernández Cerquera KM. Factores asociados al proceso de recuperación en pacientes postquirúrgicos: revisión de literatura. Sapiens in Medicine Journal. 2025[citado 11/11/2025]; 3(2), 1 -23. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=10359682
10.Albuquerque Santos RC, do Nascimento Lins E, Barros da Silva S, de Luna Alves SM, Costa dos Santos CB, Delmondes Coelho A, et al. Principais complicações no pós-operatório imediato e tardio de cirurgia cardíaca. REAEnf. 2025[citado 11/11/2025]; 25. Disponible en: https://acervomais.com.br/index.php/enfermagem/article/view/20728/11278
11.González-García F, Campechano-Hernández Y, González-Muñiz YA, Cabrera-Wrooman A. Papel de la respuesta inflamatoria en el proceso de cicatrización. TIP Revista Especializada en Ciencias Químico-Biológicas. 2025[citado 11/11/2025]; 28:1-14 Disponible en: https://tip.zaragoza.unam.mx/index.php/tip/article/view/768
12.Spicer S, Hasheminia A, Kandi S, Abu-Omar Y, Fernandez AL, El-Diasty M. Cardiac and pericardial inflammatory changes and post-cardiac surgery atrial fibrillation. Cytokine and Growth Factor Reviews. 2025[citado 11/11/2025]; 85:158–64. Disponible en: https://www.sciencedirect.com/science/article/pii/S1359610125000863?via%3Dihub
13.Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement. J Am Coll Cardiol. JACC 2025[citado 11/11/2025]. Disponible en: https://www.jacc.org/doi/epdf/10.1016/j.jacc.2025.08.047
14.Morsy MI, Friday JM, Pell JP, Lewsey J, Mackay DF, Dundas R et al. Neutrophil-to-Lymphocyte Ratio and Mortality in Cardiovascular Disease or Cancer A Population-Based Cohort Study. JACC Advances. 2026[citado 11/1/2026]; 5(1). Disponible en: https://www.sciencedirect.com/science/article/pii/S2772963X25007926?via%3Dihub
15.Dudda J, Behnes M, Weidner K, Lau F, Schmitt A, Reinhardt M, Abel N et al. Platelet counts and prognosis in heart failure with mildly reduced ejection fraction: Results from a large-scaled registry. International Journal of Cardiology. 2025[citado 11/11/2025]; 446. Disponible en: https://www.sciencedirect.com/science/article/pii/S0167527325011313?via%3Dihub
16.Galeone A, Gardellini J, Di Nicola V, Perrone F; Menzione MS, Di Gaetano R, et al. Early and Long-Term Outcomes of Patients Undergoing Surgery for Native and Prosthetic Valve Endocarditis: The Role of Preoperative Neutrophil-to-Lymphocyte Ratio, Neutrophil-to-Platelet Ratio, and Monocyte-to Lymphocyte Ratio. J. Clin. Med. 2025[citado 11/11/2025]; 14(2): 533. Disponible en: https://www.mdpi.com/2077-0383/14/2/533.
17.Porto Rödel AP, Machado Fernandes Y, Brisolara YV, Mainardi De Carvalho JA, Noal Moresco R. Role of Preoperative Inflammatory Blood Cell Indexes as a Postoperative Risk Predictor Among Patients Undergoing On-Pump Cardiac Surgery. Int J Lab Hematol. 2025[citado 11/11/2025]; 47(1):87-92. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijlh.14390
18.Yücel M, U˘guz E, Saglam MF, Erdogan KE, Hıdıroglu M, Alili A, Küçüker, ¸S.A. Predictive Role of Systemic Inflammatory Indices in Surgically Managed Postpericardiotomy Syndrome Following Cardiac Surgery. Diagnostics. 2025[citado 11/11/2025]; 15(12): 1488. Disponible en: https://www.mdpi.com/2075-4418/15/12/1488
19.Poredos P, Komadina R. Inflammation and Perioperative Cardiovascular Events. Cells. 2025[citado 11/11/2025]; 14(17): 1362. Disponible en: https://www.mdpi.com/2073-4409/14/17/1362
Small AM, Pournamdari A, Melloni Scirica BM, Bhatt DL, Raz I, Eugene Braunwald, et al. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations. JAMA Cardiol. 2024[citado 11/11/2025];9(4):385-91. Disponible en: https://jamanetwork.com/journals/jamacardiology/fullarticle/2814836
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Yulieth Maymir Palacio, Lucia Nivia Turro Mesa, Germán del Río Mesa , Germán del Río Caballero

This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
